Aside from the ability of anti-tumor cytokines to combat cancer, they can also manipulate signaling pathways (such as the NF-κB, PI3K/Akt and JAK/STAT pathways) to avoid immune detection and destruction (94-96). Here, NFKB1 is linked to cancer.